3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Active not recruiting
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
20
Lymphoma, Large B-Cell, Diffuse
16
Lymphoma
14
Neoplasms
13
Sarcoma
10
Hodgkin Disease
10
Triple Negative Breast Neoplasms
9
Lymphoma, Follicular
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, B-Cell
7
Ovarian Neoplasms
6
Burkitt Lymphoma
6
Lymphoma, Non-Hodgkin
5
Fallopian Tube Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Multiple Myeloma
4
Sarcoma, Ewing
3
Recurrence
3
Leiomyosarcoma
3
Inflammatory Breast Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Sarcoma, Synovial
2
Rhabdomyosarcoma
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neurofibrosarcoma
2
Neuroblastoma
2
Lymphoproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Interventions
Surgical Procedures, Operative
2
Paclitaxel
2
Doxorubicin
2
Cyclophosphamide
2
Carboplatin
2
pertuzumab
1
liposomal doxorubicin
1
cemiplimab
1
atezolizumab
1
Trastuzumab
1
Radiotherapy
1
Indocyanine Green
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Invasive Breast Cancer
×
Doxorubicin
×
Clear all
NCT04243616
2025-09-05
CemiHALT
Medical College of Wisconsin
Phase 2
Active not recruiting
36 enrolled
NCT03595592
2024-03-06
APTneo
Fondazione Michelangelo
Phase 3
Active not recruiting
650 enrolled